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From the accompanying paper
(Djansugurova et al., 2013), it is clear
that cancer screening is making a global
impact in reducing cancer mortality, a
major advance that will increase in value
as more therapeutic regimens become
available on a worldwide basis. The genes
of value are ones in which specific alle-
les are statistically related to oncogenesis.
The major arbitrary element is a poten-
tial bias in the functionality of the specific
panel of alleles of the gene chosen to use
for regional screening. In almost all cases,
the choices are drawn upon from the lit-
erature by their frequency of oncogenic
phenotypes, rather from the potential
mechanism of the defect (Ginsberg et al.,
2011).
There has been a disharmonious rela-
tionship between diagnostics and molec-
ular biology, with most molecular biolo-
gists feeling that these diagnostic studies
do not lead to mechanistic information.
However, based on the studies such as
those described here (Djansugurova et al.,
2013) (e.g., Schneider et al., 2008), there is
an increasing potential for diagnostic stud-
ies to provide information on the nature of
steps toward oncogenesis and to put these
studies and others into a molecular con-
text. For this to occur, a familiarity with
the gene product, and the allelic pheno-
type will lead to the most specific screens
and paths to oncogenesis.
In this study, three groups of genes
were chosen based on basic possible
correlative elements gleaned from the
literature. Although defects are present
in the “sledgehammer” genes that are
involved in the detoxification of cells,
mutations in these would be bound to
have pleiotropic and deleterious effects
without really telling us much about the
mechanism.
Hence, our interest lies in the two
remaining groups, part of the XRCC class
of genes influencing DNA damage repair.
The author states erroneously that the
XRCC1 gene is involved in DNA DSB
response, although the careful analyses
have revealed otherwise (Martinez-Macias
et al., 2013). The confusion as to path-
way is likely to be due to the possible
processing of base pair gaps into double
stranded breaks, albeit that is not their
primary defect. Indeed, XRCC1 is a scaf-
fold protein that enhances the C methyla-
tion of bases and interacts in a domain-
specific fashion with the repair associated
proteins, including APE, PARP, and Pol
β, preventing the Ogg1-mediated single
stranded nick formation via an efficient
break excision repair (BER). BER effec-
tively prevents abasic site single stranded
gap formation (Mourgues et al., 2007).
And, hence, genome stability. Consistent
with these data, the homologous yeast
Ogg1 protein methylates telomeric DNA
under oxidative stress through the creation
single stranded substrates for the BER
machinery (Lu and Liu, 2010). Clearly,
within Kazakhstan, the abasic damage of
DNA is sufficient to initiate the process
that ultimately leads to oncogenesis. The
prediction would be that the downstream
oncogenes contain a vast number of muta-
tions caused by these defects.
The study of XRCC1 with the identi-
fied specific alleles will undoubtedly start
to allow the analysis of a regulator that ulti-
mately influences BER. The phenotype of
alleles at the molecular level will be able to
define the domain structure of the protein
and the pathway leading to mechanism of
repairing abasic DNA gaps.
However, most studies use the same
panel of mutations, which may be diag-
nostically fruitful, but be mechanistically
limiting (Ginsberg et al., 2011). The diag-
nostic value of more complex protein vari-
ants that may bind to more factors may be
problematic.
Importantly, the genes that have the
predominant effect may not be disease-
specific. Rather, they may represent a
population-based clustering of genes
and alleles in specific populations and
may vary among differing populations.
Nonetheless, this study does contain some
intriguing mechanistic hints that can
be gleaned from the specific alleles that
are defective in esophagitis and cervical
cancer.
Indeed, an allele of XRCC3, a para-
log of the Rad51 DSB gene, that coats
the invading DNA strand did not have
an influence on esophageal and cervical
cancer in this region. These data sug-
gest the absence of double strand breaks
(DSB) or checkpoints involved in DSB
repair that can create a break that can
be resolved by end ligation, homologous
recombination with ectopic repeats, and a
potential site for transposition (Liu et al.,
2007). Normally, such a break would lead
to the activation of the ATM or ATR
checkpoint, and the cascade of repair
enzymes. If this pathway fails, a check-
point will be initiated in the cell cycle
to stop growth. Overcoming this check-
point is indeed a road to oncogenesis.
These data suggest that, in this popu-
lation, overall DSB-initiated repair and
checkpoint control are not involved in
the etiology of the disease. Similarly, the
absence of differences in mutations in
TP53 (Wahl et al., 1997), heavily involved
in double strand break repair and telom-
ere checkpoint control, show no signifi-
cant differences among healthy and patient
populations. Similarly, a more removed
kinase, cyclin D1 that regulates the tim-
ing of entry into the cell cycle does not
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influence the frequency of disease in this
region.
Hence, we are left with a testable
hypothesis: that inducers of mutagenesis
by BER defects are involved in the eti-
ology of the two cancers studied in this
region. These genes are likely to give rise to
oncogenic states as mutagens with a mul-
tiplicity of targets capable of producing
nonsense codons and missense mutations.
The specific targets are likely to be genes
involved in the regulation of growth con-
trol, as a secondary effect of the induc-
ers. There are likely to be a great deal
more information that will be derived
from mutations within other DNA repair-
associated genes, some of which could be
hypomorphic or haplo-insufficient alleles,
in the near future.
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